Serum Autoantibody Lowering by the Anti-FcRn Monoclonal Antibody, Nipocalimab, Correlates With Clinical Improvement in Generalized Myasthenia Gravis Patients.

Autor: Ramchandren, Sindhu, Guptill, Jeff, Antozzi, Carlo, Bril, Vera, Gamez, Josep, Meuth, Sven, Nowak, Richard, Quan, Dianna, Sevilla Mantecon, Maria Teresa, Ling, Leona, Zhu, Yaowei, Karcher, Keith, Sun, Hong
Zdroj: Neurology; 12/5/2022 Suppl 2, Vol. 99, pS35-S37, 3p
Databáze: Supplemental Index